Radiotherapy plays an indispensable role in cancer treatment, with its ability to target malignant cells and improve patient survival. However, its impact on healthy tissues poses significant challenges for reconstructive surgery. The altered tissue environment resulting from radiation, including fibrosis, vascular damage, and compromised wound healing, complicates reconstructive efforts and increases the risk of surgical complications. As cancer therapies advance, the approaches for managing radiation-induced complications must also adapt accordingly. This article explores the complex interaction between radiotherapy and reconstructive surgery, particularly in the treatment of head and neck cancers, breast reconstruction following mastectomy, and sarcoma management. Special attention is given to the customization of surgical approaches based on cancer type, with the goal of optimizing both functional and aesthetic outcomes. A multidisciplinary approach, integrating advanced imaging techniques, modern radiation delivery methods, and innovative surgical techniques is essential for improving patient outcomes.
A multinodular and vacuolating neuronal tumor (MVNT) is a rare non-malign central nervous system tumor. The cerebral cortex of young to middle-aged adults is affected and seizures and focal neurological deficits could reveal it. Despite being considered a low-grade tumor, MVNT can be challenging to diagnose and manage due to its histopathological similarities to other neuronal tumors. The limited number of reported cases makes it difficult to establish definitive guidelines for treatment and follow-up. Given the relatively recent discovery of MVNT, there is a need for further research to better understand its pathogenesis, optimal treatment and long-term strategies. Furthermore, studying MVNT can contribute to the broader understanding of brain tumor biology and the intricacies of tumor heterogeneity. This paper explores the challenges and perspectives surrounding MVNT to improve clinical decision-making and patient outcomes. Based on the present narrative review, advancements in diagnostic technologies have shown promise in addressing the challenges associated with diagnosing MVNTs. Liquid biopsy is an innovative and non-invasive diagnostic tool that analyzes biomarkers to provide information about tumors, and radiomics is a method that extracts quantitative data from medical images to provide detailed insights into tumor characteristics. Such innovative diagnostic technologies are important because they have the potential to significantly improve the current diagnostic landscape for MVNTs, allowing for earlier detection, accurate classification, and personalized treatment strategies.
NAFLD (Non-alcoholic fatty liver disease) is a condition of high importance due to its increased prevalence, estimated at 24% of the global population, and its potential progression to advanced liver disease, cirrhosis, and hepatocellular carcinoma. Onequarter of NAFLD patients have NASH (non-alcoholic steatohepatitis), which is histologically described as liver steatosis, inflammation, fibrosis, hepatocyte injury, and death. Metabolic disruptions, such as obesity, diabetes, and dyslipidemia, are considered to have a great impact on the development of NASH. Patients may have NAFLD for a long time before progressing into NASH, which highlights the necessity of periodic imaging and biochemical evaluation of the liver, and also presents an optimal window of therapeutic intervention. The challenge in developing treatment for NASH stems from the slow progression of the disease and the reliance on sequential biopsies as the diagnostic and staging tools. Several non-invasive tests have been developed as potential future alternatives to the current invasive gold standard. This review aims to assess the current available methods of diagnosis and treatment targeting inflammation.
Atypical fibroxanthoma and hemosiderotic dermatofibroma are both dermal tumors that can raise significant challenges for differential diagnosis. The definitive diagnosis is established based on histopathological appearance and immunohistochemistry. The aim of this paper is to present the differential diagnosis challenges encountered in the case of a 67-year-old male patient who developed within a month, following trauma to the lower third of the right thigh, a large asymptomatic tumor with an irregular outline.
